Apposite Capital hires ex-Bridgepoint investment exec

London-based Apposite Capital has hired Anne-Laure Meynier as an investment manager as the firm gears up to close a number of new deals.

Meynier has joined Apposite Capital from Paris-based tech start-up Nuage Labs, where she was chief financial officer, having previously worked for UK mid-market private equity firm Bridgepoint. Prior to her stint at Bridgepoint, Meynier worked in the healthcare mergers and acquisitions team at Rothschild’s global financial advisory group.

At Apposite she will work alongside the partners originating, executing and managing investments.

“We are delighted to welcome Anne-Laure to the Apposite team. With a number of new deals in the pipeline, her experience will be very valuable in assisting us to move some of these deals forwards,” David Porter, managing partner at Apposite Capital said in a statement.

Apposite Capital is a healthcare-focused private equity firm making investments of typically between £10 and £20 million ($15 million-$30 million; €14 million-$28 million). This summer the firm sold Cancer Partners UK to GenesisCare, Australia’s largest provider of radiotherapy services. The investor currently has around $220 million assets under management.